Skip to main content

CAP TODAY/Thermo Fisher Scientific/Cancer Genetics Incorporated Webinar: Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC multiple biomarker testing

Thank you

This live web event has ended. Thank you for attending.



Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

Why should you register now for this webinar?
To learn the how and why of NGS testing for NSCLC therapy selection
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Boaz Kurtis, MD

What will be discussed in this webinar?

How to practice precision oncology based on fast-changing guidelines and to
ensure even challenging samples get tested to achieve best outcomes for
as many NSCLC patients as possible
Cancer Genetics Inc. (CGI) testing model, case studies and lessons learned
Ask your questions of our distinguished presenter

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher.


  • Bob McGonnagle

    Publisher, CAP TODAY

  • Boaz Kurtis, MD

    Medical Director, Cancer Genetics, Inc.

March 28, 2018
Wed 1:00 PM EDT

Duration 1H 0M

This live web event has ended.